These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 16123554

  • 1. Deep sclerectomy versus punch trabeculectomy: effect of low-dosage mitomycin C.
    Cillino S, Di Pace F, Casuccio A, Lodato G.
    Ophthalmologica; 2005; 219(5):281-6. PubMed ID: 16123554
    [Abstract] [Full Text] [Related]

  • 2. Deep sclerectomy versus trabeculectomy with low-dosage mitomycin C: four-year follow-up.
    Cillino S, Di Pace F, Casuccio A, Cillino G, Lodato G.
    Ophthalmologica; 2008; 222(2):81-7. PubMed ID: 18303227
    [Abstract] [Full Text] [Related]

  • 3. Deep sclerectomy versus punch trabeculectomy with or without phacoemulsification: a randomized clinical trial.
    Cillino S, Di Pace F, Casuccio A, Calvaruso L, Morreale D, Vadalà M, Lodato G.
    J Glaucoma; 2004 Dec; 13(6):500-6. PubMed ID: 15534477
    [Abstract] [Full Text] [Related]

  • 4. Deep sclerectomy augmented with combination of absorbable biosynthetic sodium hyaluronate scleral implant and mitomycin C or with mitomycin C versus trabeculectomy: long-term results.
    Mesci C, Erbil HH, Karakurt Y, Akçakaya AA.
    Clin Exp Ophthalmol; 2012 Dec; 40(4):e197-207. PubMed ID: 21668789
    [Abstract] [Full Text] [Related]

  • 5. Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study.
    Ollikainen ML, Puustjärvi TJ, Rekonen PK, Uusitalo HM, Teräsvirta ME.
    Acta Ophthalmol; 2011 Sep; 89(6):548-55. PubMed ID: 19925527
    [Abstract] [Full Text] [Related]

  • 6. Mitomycin-C-augmented deep sclerectomy in patients with primary open-angle glaucoma and exfoliation glaucoma: a 1-year prospective study.
    Ollikainen M, Puustjärvi T, Rekonen P, Uusitalo H, Teräsvirta M.
    Acta Ophthalmol; 2010 Feb; 88(1):20-6. PubMed ID: 19432842
    [Abstract] [Full Text] [Related]

  • 7. A randomised, prospective study comparing trabeculectomy with viscocanalostomy with adjunctive antimetabolite usage for the management of open angle glaucoma uncontrolled by medical therapy.
    O'Brart DP, Shiew M, Edmunds B.
    Br J Ophthalmol; 2004 Aug; 88(8):1012-7. PubMed ID: 15258016
    [Abstract] [Full Text] [Related]

  • 8. Nonpenetrating deep sclerectomy with the use of adjunctive mitomycin C.
    Neudorfer M, Sadetzki S, Anisimova S, Geyer O.
    Ophthalmic Surg Lasers Imaging; 2004 Aug; 35(1):6-12. PubMed ID: 14750756
    [Abstract] [Full Text] [Related]

  • 9. Phacoemulsification-deep sclerectomy modified by trabeculum microperforations and implantation of lens anterior capsule as autologous scleral implant.
    Rekas M, Rudowicz J, Lewczuk K, Kluś A, Pawlik B, Stankiewicz A.
    Curr Med Res Opin; 2010 Aug; 26(8):2025-32. PubMed ID: 20590394
    [Abstract] [Full Text] [Related]

  • 10. Trabeculectomy with mitomycin C combined with direct cauterization of peripheral iris in the management of neovascular glaucoma.
    Elgin U, Berker N, Batman A, Simsek T, Cankaya B.
    J Glaucoma; 2006 Oct; 15(5):466-70. PubMed ID: 16988612
    [Abstract] [Full Text] [Related]

  • 11. Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma.
    Kozobolis VP, Christodoulakis EV, Tzanakis N, Zacharopoulos I, Pallikaris IG.
    J Glaucoma; 2002 Aug; 11(4):287-93. PubMed ID: 12169964
    [Abstract] [Full Text] [Related]

  • 12. Deep sclerectomy with mitomycin C in failed trabeculectomy.
    Rebolleda G, Muñoz-Negrete FJ.
    Eye (Lond); 2007 Jan; 21(1):23-8. PubMed ID: 16311522
    [Abstract] [Full Text] [Related]

  • 13. Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up.
    Cillino S, Casuccio A, Di Pace F, Cagini C, Ferraro LL, Cillino G.
    BMC Ophthalmol; 2016 Mar 05; 16():24. PubMed ID: 26946419
    [Abstract] [Full Text] [Related]

  • 14. Modified deep sclerectomy (D-lectomy MMC) for primary open-angle glaucoma: preliminary results.
    Chihara E, Okazaki K, Takahashi H, Shoji T, Adachi H, Hayashi K.
    J Glaucoma; 2009 Feb 05; 18(2):132-9. PubMed ID: 19225350
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of deep sclerectomy and phacoemulsification and deep sclerectomy in clinical material of Military Health Service Institute--yearly observations.
    Marek R, Joanna W, Lewczuk K, Siemiatkowska A, Stankiewicz A.
    Klin Oczna; 2006 Feb 05; 108(10-12):385-91. PubMed ID: 17455710
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Delayed post-operative use of 5-fluorouracil as an adjunct in medically uncontrolled open angle glaucoma.
    Mastropasqua L, Carpineto P, Ciancaglini M, Zuppardi E, Lobefalo L, Gallenga PE.
    Eye (Lond); 1998 Feb 05; 12 ( Pt 4)():701-6. PubMed ID: 9850268
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial.
    Costa VP, Azuara-Blanco A, Netland PA, Lesk MR, Arcieri ES.
    Ophthalmology; 2004 Jun 05; 111(6):1071-6. PubMed ID: 15177955
    [Abstract] [Full Text] [Related]

  • 19. E-PTFE (Gore-Tex) implant with or without low-dosage mitomycin-C as an adjuvant in penetrating glaucoma surgery: 2 year randomized clinical trial.
    Cillino S, Zeppa L, Di Pace F, Casuccio A, Morreale D, Bocchetta F, Lodato G.
    Acta Ophthalmol; 2008 May 05; 86(3):314-21. PubMed ID: 17995980
    [Abstract] [Full Text] [Related]

  • 20. Nine-year follow-up of trabeculectomy with or without low-dosage mitomycin-c in primary open-angle glaucoma.
    Reibaldi A, Uva MG, Longo A.
    Br J Ophthalmol; 2008 Dec 05; 92(12):1666-70. PubMed ID: 18782799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.